A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma.

Neurooncol Adv · 2023 · PMC10406429 · PMID 37554225

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Most tadalafil patients also showed a decreasing trend of the immunosuppressive regulatory T cells (Treg) at week 6 (11 out of 15 or 73%; Figure 2D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.